Tertiary lymphoid structures (TLS) are lymph node-like organisations of immune cells within inflamed tissues that can drive immune cell activation. Solid tumours exhibit TLS development, which is associated with improved survival of untreated patients. Similarly, in patients treated with immune checkpoint inhibitors, TLS development is often associated with improved therapeutic response. This has prompted the hypothesis that TLS are sites where antitumor immunity is generated. For this webinar, the speaker will introduce what is already known about TLS, what the main open questions are, and what analysis approaches can be used to understand the biology of tumor-associated TLS.
In this webinar Dr. Silina will introduce what is already known about tertiary lymphoid structures (TLS), what the main open questions are, and what analysis approaches can be used to understand the biology of tumor-associated TLS.
In this Webinar You Will:
- Learn about the development and function of tertiary lymphoid structures (TLS) in the cancer microenvironment
- Discover the prognostic and predictive relevance of TLS in cancer
- Find out about methods for in-depth characterization of TLS in human tissues
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…